Joseph Sinkule - 22 Jul 2025 Form 4 Insider Report for Klotho Neurosciences, Inc. (KLTO)

Signature
Joseph Sinkule
Issuer symbol
KLTO
Transactions as of
22 Jul 2025
Net transactions value
$0
Form type
4
Filing time
08 Aug 2025, 06:00:17 UTC
Next filing
29 Sep 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
SINKULE JOSEPH Chief Executive Officer, Director 1300 SOUTH BOULEVARD SUITE D, CHARLOTTE Joseph Sinkule 07 Aug 2025 0001524409

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KLTO Common Stock Other -2,000,000 -34% 3,909,520 22 Jul 2025 Direct F1, F2, F3
transaction KLTO Common Stock Award +537,180 +14% 4,446,700 05 Aug 2025 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On July 22, 2025 and August 6, 2025, the Reporting Person transferred and pledged a total of 2,000,000 shares to Stock Loan Solutions, LLC ("Lender") as collateral for a non-recourse loan. The term of the loan is 3 years. The Reporting Person intends to use a portion of the proceeds from the term loan to liquidate some personal obligations. As beneficial owner of the shares pledged to it as collateral, Lender may take any and all actions with respect to such shares, including selling, assigning, transferring, pledging, hypothecating, lending, or encumbering the same, or enter into hedging arrangements, or create and trade derivative instruments backed by such shares as called for in the loan agreements.
F2 Absent a default, the Reporting Person retains a conditional right to exercise the voting rights applicable to such shares. Within five business days of the Reporting Person's repayment of the loan, the Lender must transfer the Shares to the Reporting Person, subject to the Lender's right to withhold and set off against the Shares any sums owed to the Lender by the Reporting Person under the loan agreement. Despite the parties' intention for the Lender to transfer the Shares to the Reporting Person after the Loan is repaid, the Lender may be deemed to beneficially own the Shares during the Loan term.
F3 Includes 1,000,000 shares issuable upon the exercise of incentive options.
F4 The Reporting Person received the shares as contingent merger consideration.